Because as a patient investor with a long term view (as one should be with medical investments), a few cents here and there won't make that much of a difference either way.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025